Bayer's Betaferon Approved In China; Launch Likely In Mid 2010
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Germany-based Bayer Schering Pharma announced Dec. 1 that China's State FDA approved its multiple sclerosis treatment Betaferon/Betaseron (interferon beta-1b). Bayer plans to launch the drug by mid-2010